Target Name: CACHD1
NCBI ID: G57685
Review Report on CACHD1 Target / Biomarker Content of Review Report on CACHD1 Target / Biomarker
CACHD1
Other Name(s): RP4-655E10.1 | cache domain-containing protein 1 | CACHD1 variant 1 | VWFA and cache domain-containing protein 1 (isoform 2) | CAHD1_HUMAN | CACHD1 variant 2 | VWFA and cache domain-containing protein 1 | Cache domain-containing protein 1 | VWFA and cache domain-containing protein 1 isoform 1 precursor (isoform 1) | Von Willebrand factor type A and cache domain containing 1 | VWCD1 | KIAA1573 | Cache domain containing 1, transcript variant 1 | Cache domain containing 1, transcript variant 2 | cache domain containing 1 | von Willebrand factor type A and cache domain containing 1

RP4-655E10.1: A Protein Regulating Calcium Homeostasis

CACHD1 (RP4-655E10.1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its primary function is to regulate the balance of phosphate and calcium in these tissues, which is essential for many cellular processes, including muscle contractions, nerve function, and cell signaling.

RP4-655E10.1, or CACHD1, is a member of the Calbindin gene family, which encodes a family of calcium-binding proteins. These proteins are involved in a variety of physiological processes in the body, including bone development and maintenance, nerve function, and hormone regulation.

One of the unique features of RP4-655E10.1 is its ability to interact with other proteins that are involved in the regulation of calcium homeostasis. This interaction is critical for the proper functioning of many physiological processes in the body, including muscle contractions, nerve function, and cell signaling.

RP4-655E10.1 has also been shown to play a role in the development and maintenance of certain diseases, including cancer. For example, studies have shown that high levels of CACHD1 expression are associated with poor prognosis in patients with pancreatic cancer, a highly aggressive form of this disease.

In addition to its potential role in cancer, RP4-655E10.1 is also a drug target (or biomarker) of interest. Researchers are currently studying the potential uses of drugs that target RP4-655E10.1 in the treatment of various diseases, including cancer.

One approach to targeting RP4-655E10.1 with drugs is to use small molecules that can modulate its activity. For example, researchers have synthesized a number of compounds that can bind to RP4-655E10.1 and alter its function. These compounds have been shown to be effective in preclinical studies in treating a variety of diseases, including cancer.

Another approach to targeting RP4-655E10.1 is to use antibodies that can specifically recognize and label the protein. These antibodies have been shown to be effective in preclinical studies in treating a variety of diseases, including cancer.

RP4-655E10.1 is a protein that has significant implications for the study of cellular processes in the body. Its ability to interact with other proteins involved in the regulation of calcium homeostasis makes it an attractive target for the development of drugs and other therapies for a variety of diseases.

In conclusion, RP4-655E10.1 is a protein that has been shown to play a critical role in the regulation of calcium homeostasis in various tissues of the body. Its potential as a drug target (or biomarker) makes it an attractive target for the development of therapies for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Cache Domain Containing 1

Functions: May regulate voltage-dependent calcium channels

The "CACHD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CACHD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4 | CALHM5 | CALHM6 | CALM1 | CALM2 | CALM2P1 | CALM2P2 | CALM3 | CALML3 | CALML3-AS1 | CALML4 | CALML5 | CALML6 | Calmodulin | CALN1 | Calpain | Calpain-13 | Calprotectin | CALR | CALR3 | CALU | CALY | CAMK1 | CAMK1D | CAMK1G | CAMK2A | CAMK2B | CAMK2D | CAMK2G | CAMK2N1 | CAMK2N2 | CAMK4 | CAMKK1 | CAMKK2 | CAMKMT | CAMKV | CAMLG